Aim 1 Identifying druggable Targets for potential ARSACS treatment

Aim 2 Characterize pathophysiology for future druggable target development

Duration : 2nd year of the funded project
Grant: $50,000

Dr. Anne McKinney

Dr. Anne McKinney, Department of Pharmacology and Therapeutics, McGill University Bellini Life Sciences Bldg
3469 Sir William Osler, Montreal, Quebec Canada H3G 0B1
Tel: (514)-398-5685; Fax: (514)-398-2045; Email: